RhumbLine Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,536
Closed -$79K 3014
2019
Q1
$79K Buy
4,536
+49
+1% +$853 ﹤0.01% 2888
2018
Q4
$61K Buy
4,487
+1,314
+41% +$17.9K ﹤0.01% 2928
2018
Q3
$68K Sell
3,173
-8
-0.3% -$171 ﹤0.01% 2895
2018
Q2
$136K Buy
3,181
+305
+11% +$13K ﹤0.01% 2835
2018
Q1
$188K Buy
2,876
+410
+17% +$26.8K ﹤0.01% 2621
2017
Q4
$180K Sell
2,466
-348
-12% -$25.4K ﹤0.01% 2662
2017
Q3
$258K Buy
2,814
+42
+2% +$3.85K ﹤0.01% 2617
2017
Q2
$183K Sell
2,772
-36
-1% -$2.38K ﹤0.01% 2789
2017
Q1
$609K Buy
2,808
+91
+3% +$19.7K ﹤0.01% 2166
2016
Q4
$251K Buy
2,717
+79
+3% +$7.3K ﹤0.01% 2575
2016
Q3
$357K Sell
2,638
-739
-22% -$100K ﹤0.01% 2390
2016
Q2
$342K Buy
3,377
+887
+36% +$89.8K ﹤0.01% 2450
2016
Q1
$408K Buy
2,490
+9
+0.4% +$1.48K ﹤0.01% 2355
2015
Q4
$813K Buy
2,481
+81
+3% +$26.5K ﹤0.01% 1940
2015
Q3
$774K Sell
2,400
-80
-3% -$25.8K ﹤0.01% 1939
2015
Q2
$988K Buy
2,480
+45
+2% +$17.9K ﹤0.01% 1879
2015
Q1
$1.2M Buy
2,435
+409
+20% +$201K ﹤0.01% 1744
2014
Q4
$725K Buy
2,026
+191
+10% +$68.3K ﹤0.01% 2017
2014
Q3
$354K Sell
1,835
-22
-1% -$4.24K ﹤0.01% 2431
2014
Q2
$444K Buy
1,857
+171
+10% +$40.9K ﹤0.01% 2351
2014
Q1
$431K Sell
1,686
-46
-3% -$11.8K ﹤0.01% 2316
2013
Q4
$343K Hold
1,732
﹤0.01% 2506
2013
Q3
$293K Buy
1,732
+4
+0.2% +$677 ﹤0.01% 2541
2013
Q2
$307K Buy
+1,728
New +$307K ﹤0.01% 2621